<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03003585</url>
  </required_header>
  <id_info>
    <org_study_id>Asozkan-2</org_study_id>
    <nct_id>NCT03003585</nct_id>
  </id_info>
  <brief_title>Effects of Direct Laryngoscopic and Fiberoptic Intubation on Intraocular Pressure</brief_title>
  <official_title>Comparison of Effects of Direct Laryngoscopic and Fiberoptic Oral Endotracheal Intubation on Intraocular Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators aimed to compare the effects of direct laryngoscopic and&#xD;
      fiberoptic endotracheal intubation on intraocular pressure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Material and Method: Total of 54 American Society of Anesthesiologist Grade 1-2, Mallampati&#xD;
      score 1 or 2, age between 18 to 65 patient planned to undergo nonopthalmic surgery will be&#xD;
      included to study. Patients with glaucoma, diabetes mellitus, cardiovascular and pulmonary&#xD;
      diseases, American Society of Anesthesiologist Grade III and IV, body mass index more than&#xD;
      35, difficult intubation, undergo obstetrical surgery and propofol, fentanyl, rocuronium&#xD;
      contraindicated will be excluded from the study. Patients will be divided randomly into 2&#xD;
      groups as direct laryngoscopic and fiberoptic intubation group. Patients will be&#xD;
      preoxygenated with %100 O2 for 3 minutes then anesthesia will be induced using propofol 2 mg&#xD;
      / kg, fentanyl 1 mcg/kg, and rocuronium 0,5 mg / kg in both groups. After 3 minutes mask&#xD;
      ventilation, patients will be intubated (women with No:7-7,5, men with No:8-8,5 intubation&#xD;
      tube). Systolic blood pressure, diastolic blood pressure, mean arterial pressure, peripheral&#xD;
      oxygen saturation,perfusion index will be recorded and intraocular pressure measured by&#xD;
      ophthalmologist by tonopen device will be recorded pre-induction (basal), after induction,&#xD;
      1,2,3,5 minutes after intubation, respectively. Period between handling of laryngoscope or&#xD;
      fiberoptic device after termination of mask ventilation and obtain end tidal CO2 will be&#xD;
      accepted as application time and recorded. Study will be terminated after 5th minute values&#xD;
      taken.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Actual">April 4, 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>From Beginning of Anesthesia induction to 5th minutes of intubation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rate</measure>
    <time_frame>From Beginning of Anesthesia induction to 5th minutes of intubation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>within the first 24 hour after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>From Beginning of Anesthesia induction to 5th minutes of intubation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Intraocular Pressure</condition>
  <condition>Intubation Complication</condition>
  <arm_group>
    <arm_group_label>Fiberoptic bronchoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Evaluate the difference between the two groups about hemodynamic and intraocular pressure responses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Direct laryngoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Evaluate the difference between the two groups about hemodynamic and intraocular pressure responses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Direct laryngoscope</intervention_name>
    <description>This device is used in endotracheal intubation and tonopen device for measuring of intraocular pressure. The investigators want to evaluate which one is better.</description>
    <arm_group_label>Direct laryngoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fiberoptic bronchoscope</intervention_name>
    <description>This device is used in endotracheal intubation and tonopen device for measuring of intraocular pressure. The investigators want to evaluate which one is better.</description>
    <arm_group_label>Fiberoptic bronchoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA (American Society of Anesthesiologist) Grade 1-2,&#xD;
&#xD;
          -  Mallampati score 1 or 2,&#xD;
&#xD;
          -  Age between 18 to 65&#xD;
&#xD;
          -  Patient planned to undergo nonopthalmic surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with glaucoma, diabetes mellitus, cardiovascular and pulmonary diseases, ASA&#xD;
             Grade III and IV, BMI more than 35,&#xD;
&#xD;
          -  Patients with difficult intubation,&#xD;
&#xD;
          -  Patients undergoing obstetrical surgery and propofol, fentanyl, rocuronium&#xD;
             contraindicated.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>December 22, 2016</study_first_submitted>
  <study_first_submitted_qc>December 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2016</study_first_posted>
  <last_update_submitted>April 4, 2017</last_update_submitted>
  <last_update_submitted_qc>April 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>Ahmet Selim Ozkan</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>intraocular pressure</keyword>
  <keyword>direct laryngoscopy</keyword>
  <keyword>fiberoptic bronchoscopy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

